These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Protein engineering strategies. Whitlow M Targeted Diagn Ther; 1992; 7():55-61. PubMed ID: 1633309 [No Abstract] [Full Text] [Related]
46. Immunoconjugates and immunotoxins for therapy of solid tumors. Hellström I; Trail P; Siegall C; Firestone R; Hellström KE Cancer Chemother Pharmacol; 1996; 38 Suppl():S35-6. PubMed ID: 8765413 [No Abstract] [Full Text] [Related]
47. Vascular targeting--a new approach to the therapy of solid tumors. Burrows FJ; Thorpe PE Pharmacol Ther; 1994 Oct; 64(1):155-74. PubMed ID: 7846113 [TBL] [Abstract][Full Text] [Related]
48. Immunotoxins in the therapy of cancer: from bench to clinic. Ghetie V; Vitetta E Pharmacol Ther; 1994 Sep; 63(3):209-34. PubMed ID: 7831391 [TBL] [Abstract][Full Text] [Related]
49. Immunotoxins: status and prospects. Spooner RA; Lord JM Trends Biotechnol; 1990 Jul; 8(7):189-93. PubMed ID: 1366624 [TBL] [Abstract][Full Text] [Related]
50. [Protein engineering of Pseudomonas exotoxin and its targeting therapy of cancer]. Kondo T Tanpakushitsu Kakusan Koso; 1989 Oct; 34(13):1793-803. PubMed ID: 2513619 [No Abstract] [Full Text] [Related]
51. Recent development and optimization of pseudomonas aeruginosa exotoxin immunotoxins in cancer therapeutic applications. Wu T; Zhu J Int Immunopharmacol; 2021 Jul; 96():107759. PubMed ID: 34162138 [TBL] [Abstract][Full Text] [Related]
52. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology]. Chiron MF Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366 [TBL] [Abstract][Full Text] [Related]
53. General strategies in in vivo animal modeling. Vallera DA; Blazar BR Targeted Diagn Ther; 1992; 7():63-77. PubMed ID: 1633310 [No Abstract] [Full Text] [Related] [Previous] [New Search]